About: Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1997 (uk) article scientifique publié en 1997 (fr) im August 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 1997 (ast) scientific article published on 01 August 1997 (en)
publication date	wds:Q73668443-8C639859-8827-4D76-920F-147ED6CBFE42
publication date	1997-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73668443-D8AA648B-4636-4029-98BE-7D1978ACA0B0
language of work or name	English
cites work	wds:Q73668443-0655C46E-E1E7-43E8-9D63-65AAA12DA9FA wds:Q73668443-0CCCDE64-51FD-4859-AB1E-7C148A0D2401 wds:Q73668443-1F368A46-7228-4A0D-95B7-A3473934738F wds:Q73668443-22480A0E-B923-4B68-8037-712D8E9C0474 wds:Q73668443-3354C4B3-A322-4FAC-8F02-C1624BCFEF4B wds:Q73668443-6F2CF089-CE67-4FA1-BF5B-47C035B1C9D8 wds:Q73668443-7AED9A31-11FD-452D-B8AA-AEB3F90484DD wds:Q73668443-8BFB2114-DA14-47BD-BBEE-DB1A4C6851DF wds:Q73668443-A7FDBD68-55F1-45EA-8183-2976E0977691 wds:Q73668443-B22DDF65-2271-46A6-8027-A8F28148ED0A wds:Q73668443-B7BA10A4-2C0C-4B59-B88E-FA9367A9FDC9 wds:Q73668443-BBEB308C-EEEC-4959-BA6E-2078AE58F446 wds:Q73668443-C4AB9976-1FB3-482D-8AE5-2540C56D26A9 wds:Q73668443-D19BDDE4-37F2-46DD-83F3-B7EA76909D50 wds:Q73668443-D1E264DD-ED2E-4760-902F-07AD14A45441 wds:Q73668443-D885F599-EF81-4D12-A712-381332FA898A wds:Q73668443-E169E62D-872A-4266-B4F3-201CFBD02D0E wds:Q73668443-E1C871CB-AA70-44DF-AA5C-16DE3F4CF468 wds:Q73668443-F0AD3370-737F-4A52-AE49-3C8F7F9D4D63
cites work	Anabolic Actions of Parathyroid Hormone on Bone* Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis An evaluation of antibodies and clinical resistance to salmon calcitonin Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial Resistance to bone resorbing effects of PTH in black women Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats Calcium homeostasis of an elderly population upon admission to a nursing home Nasal calcitonin for treatment of established osteoporosis Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses Pathogenesis of osteoporosis
author name string	wds:Q73668443-0A1E8A40-14FE-45F4-BAE9-49D9724A6218 wds:Q73668443-20D10D19-B477-430C-8B6E-826CAD827542 wds:Q73668443-46CBDBAB-9408-4E56-858F-509A8D07DF49 wds:Q73668443-72EAAADF-ACF3-4CC2-9954-4B4D705482A1 wds:Q73668443-81488F05-EAA7-4162-B767-FA4F27EC2536 wds:Q73668443-83C5A1A0-74B4-4638-A318-8C9C64FB5262 wds:Q73668443-87207917-7705-42EA-8B9B-1406682E0A22 wds:Q73668443-B3140E19-6245-474A-AF5D-27892BD40EA1
author name string	R Lindsay V Shen J Nieves F Cosman E Henneman D Dempster C Formica L Woelfert
rdfs:label	Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis (en) Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis (nl)
skos:prefLabel	Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis (en) Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis (nl)
name	Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis (en) Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis (nl)
title	wds:Q73668443-6765FCE5-3BDF-49D7-A817-6F6F10851D7D
title	Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis (en)
page(s)	wds:Q73668443-BBA14439-CD11-4D46-9825-C25E2090CBEB
page(s)	550-555
instance of	wds:Q73668443-E1C4AD8F-AF1E-4E1E-B43C-7F11C22C95CD
instance of	scholarly article
main subject	wds:Q73668443-5855D47F-4A17-4A81-B235-9FD6E51FE39E wds:Q73668443-A9C43B2E-319B-4F23-8E35-3C9128805DDF
main subject	estrogen bone fracture
PubMed ID	wds:Q73668443-E90BB1BD-9FE4-47DF-8101-ED9492B8F7D4
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9284777
PubMed ID	9284777
published in	wds:Q73668443-463CC6B0-99C6-4C35-9EDF-B4834240F756
published in	The Lancet
issue	wds:Q73668443-70FCB472-04D2-4CA6-8441-1E207FFD2F0D
volume	wds:Q73668443-6D5E403F-DD3E-42F9-8DD7-DD70C30001A6
issue	9077
volume	350
DOI	wds:Q73668443-E3122EE2-A214-40D0-A83A-F30AFB4F3479
DOI	http://dx.doi.org/10.1016/S0140-6736(97)02342-8
DOI	10.1016/S0140-6736(97)02342-8
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73668443
is cites work of	Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis Drug insight: Existing and emerging therapies for osteoporosis Advances in Nanotechnology for the Treatment of Osteoporosis Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies. Parathyroid hormone analogues in the treatment of osteoporosis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software